Ultrasound for Erectile Dysfunction

N/A

Recruiting

Led By Matthew Ziegelmann, MD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3 months, 6 months and 9 months post-prostatectomy

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to investigate if adding vibroelastography, a noninvasive ultrasound technique, to the standard penile duplex Doppler ultrasound can help evaluate tissue fibrosis and erectile function recovery after

Who is the study for?

Men over 40 with early-stage prostate cancer (low to intermediate risk) and mild or no erectile dysfunction, as measured by a score of ≥21 on the IIEF. They must be interested in preserving sexual function and planning to undergo nerve-sparing prostatectomy surgery.

What is being tested?

The trial is testing Ultrasound Vibroelastography (UVE), a noninvasive technique, alongside standard penile duplex Doppler ultrasound to see if it better assesses erectile function recovery after prostate cancer surgery.

What are the potential side effects?

Since UVE is a diagnostic procedure using ultrasound, side effects are minimal but may include discomfort during the procedure or minor skin irritation.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3 months, 6 months and 9 months post-prostatectomy

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3 months, 6 months and 9 months post-prostatectomy

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 6 months and 9 months post-prostatectomy for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Viscoelasticity

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Ultrasound viscoelastography (UVE) in radical proctectomy recoveryExperimental Treatment1 Intervention

Subjects undergoing radical prostatectomy for prostate cancer disease as standard of care will have a ultrasound vibroelastography performed before surgery, 3 months, 6 months and 9 months post-prostatectomy.

Do I qualify?Apply below to find out